Albuminuria and tolvaptan in autosomal-dominant polycystic kidney disease: results of the TEMPO 3:4 Trial

Short-term Effects of Tolvaptan in Individuals With Autosomal Dominant Polycystic Kidney Disease at Various Levels of Kidney Function

(2015) Wendy E. Boertien et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

A New Equation to Estimate Glomerular Filtration Rate

(2013) Andrew S. Levey et al.   ANNALS OF INTERNAL MEDICINE

Short-term renal hemodynamic effects of tolvaptan in subjects with autosomal dominant polycystic kidney disease at various stages of chronic kidney disease

(2013) Wendy E. Boertien et al.   KIDNEY INTERNATIONAL

Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention

(2013) Ron T Gansevoort et al.   LANCET

Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease

(2012) Vicente E. Torres et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rationale and Design of the TEMPO (Tolvaptan Efficacy and Safety in Management of Autosomal Dominant Polycystic Kidney Disease and Its Outcomes) 3-4 Study

(2011) Vicente E. Torres et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Potential Deleterious Effects of Vasopressin in Chronic Kidney Disease and Particularly Autosomal Dominant Polycystic Kidney Disease

(2011) E. Meijer et al.   KIDNEY & BLOOD PRESSURE RESEARCH

Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts

(2011) Ron T. Gansevoort et al.   KIDNEY INTERNATIONAL

Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts

(2011) Brad C. Astor et al.   KIDNEY INTERNATIONAL

Short-term effects of tolvaptan on renal function and volume in patients with autosomal dominant polycystic kidney disease

(2011) Maria V. Irazabal et al.   KIDNEY INTERNATIONAL

Association of Urinary Biomarkers With Disease Severity in Patients With Autosomal Dominant Polycystic Kidney Disease: A Cross-sectional Analysis

(2010) Esther Meijer et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Early Renal Abnormalities in Autosomal Dominant Polycystic Kidney Disease

(2010) E. Meijer et al.   Clinical Journal of the American Society of Nephrology

Potentially Modifiable Factors Affecting the Progression of Autosomal Dominant Polycystic Kidney Disease

(2010) V. E. Torres et al.   Clinical Journal of the American Society of Nephrology

Intensive Blood-Pressure Control in Hypertensive Chronic Kidney Disease

(2010) Lawrence J. Appel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Lowering Blood Pressure Reduces Renal Events in Type 2 Diabetes

(2009) B. E. de Galan et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Glomerular and proximal tubule cysts as early manifestations of Pkd1 deletion

(2009) Ali K. Ahrabi et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Effects of Strict Blood Pressure Control by a Long-Acting Calcium Channel Blocker on Brain Natriuretic Peptide and Urinary Albumin Excretion Rate in Japanese Hypertensive Patients

(2008) Hideyuki UNO et al.   HYPERTENSION RESEARCH